Omeros reported $0 in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US USD 507K 63K
Adma Biologics ADMA:US USD 41.09M 7.18M
Aerie Pharmaceuticals AERI:US USD 36.13M 2.82M
Alnylam Pharmaceuticals ALNY:US USD 264.31M 39.49M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Cytokinetics CYTK:US USD 2.51M 86.45M
Dynavax Technologies DVAX:US USD 167.74M 88.73M
Gilead Sciences GILD:US USD 7.04B 782M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Insmed INSM:US USD 67.73M 2.51M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Knight Therapeutics Inc GUD:CN CAD 72.28M 3.54M
Macrogenics MGNX:US USD 41.73M 15.73M
Mirati Therapeutics MRTX:US USD 5.43M 69K
Pacira Pharmaceuticals PCRX:US USD 167.47M 1.94M
Pfizer PFE:US USD 22.64B 5.1B
Sangamo Biosciences SGMO:US USD 26.46M 2.92M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
United Therapeutics UTHR:US USD 516M 49.1M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
Xoma XOMA:US USD 451K 532K